Centivax

Developer of a broad-spectrum vaccine designed to treat and eradicate rapidly mutating pathogens. The company utilizes computational immune engineering to develop therapeutic monoclonal antibodies aga...

Healthcare

South San Francisco, CA, United States

Founded 2019

27 employees

Website

Valuation

$95M

Market implied

Share Price

N/A

Total Raised

$55M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Centivax's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required